Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

McCann Health Promotes Charlie Buckwell to President, EMEA

Michel Nakache also promoted by McCann Health to Head of Global Clients Unit

Read More »

Chipotle’s shares drop after latest food safety incident

Shares of Chipotle Mexican Grill Inc fell almost 6 percent in morning trading on Wednesday, a day after the popular burrito chain operator said it would temporarily shut a Massachusetts restaurant after four employees fell sick. Chipotle is trying to repair its reputation after a series of food-safety incidents, including two E. coli outbreaks that […]

Read More »

Roche receives CFDA approval for CINtec PLUS Cytology test

Roche receives approval in China for the CINtec PLUS Cytology test …

Read More »

Bristol-Myers Squibb says stops some initiatives in China

U.S. drugmaker Bristol-Myers Squibb said on Tuesday it had stopped “certain initiatives” in China …

Read More »

Sanofi and Merck pull the plug on European vaccines venture

Sanofi SA and Merck & Co. Inc. announced that they are ending a 22-year-old joint venture to sell vaccines in Europe …

Read More »

Gilead, Merck & Co. Duke It Out Over Hep C $1,000-Pill Royalties

March 8, 2016 By Alex Keown, Breaking News Staff   FOSTER CITY, Calif. – Gilead Sciences (GILD) could owe Merck (MRK) more than $3 billion in a patent dispute over its block buster hepatitis C treatment if a jury finds Merck’s own hepatitis C patents are still viable, Bloomberg reported this morning. Merck challenged […]

Read More »

U.S. industry body says India agreed to not issue ‘compulsory’ drug licenses

India has given private assurances that it will not grant licences allowing local firms to override patents and make cheap copies of drugs by big Western drugmakers, a U.S. business advocacy group said.   The comments were revealed in a submission last month by the U.S.-India Business Council (USIBC) to the U.S. Trade Representative (USTR), […]

Read More »

People with anxiety may be hard-wired to see world differently

People with anxiety may not be able to distinguish between neutral and threatening stimuli as well as individuals without anxiety, a small study suggests. Researchers designed a sound experiment to explore the brain’s plasticity, or its ability to change and respond to new situations. These changes influence how the brain reacts to stimuli and whether […]

Read More »

Being ‘out of shape’ ups diabetes risk regardless of weight

For adolescents, low cardiorespiratory fitness and poor muscle strength increase their risk for type 2 diabetes later in life, regardless of body weight, according to a study of young men in Sweden. “Not only were both low aerobic and muscular fitness linked with a higher long-term risk of diabetes, but this was true even among […]

Read More »

Celldex discontinues late-stage study of brain cancer vaccine

Celldex Therapeutics Inc said it would discontinue a late-stage study of its brain cancer vaccine after an independent interim analysis suggested the therapy might not show a statistically significant benefit in patient survival compared with standard chemotherapy. Celldex shares more than halved to $3.76 in premarket trading on Monday. The vaccine, Rintega, belongs to an […]

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

June 2019 Focus: Payer access, biotech/biopharma, DTC, rare diseases, and more!


Ad Right Bottom